Difference between revisions of "Template:Article of the week"

From LIMSWiki
Jump to navigationJump to search
(Updated article of the week text)
(Updated article of the week text)
(One intermediate revision by the same user not shown)
Line 1: Line 1:
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Tab2 Valdes-Donoso CaliforniaAg2019 73-3.jpg|240px]]</div>
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig1 Wang BMCMedInfoDecMak2019 19-1.png|240px]]</div>
'''"[[Journal:Costs of mandatory cannabis testing in California|Costs of mandatory cannabis testing in California]]"'''
'''"[[Journal:Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory|Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory]]"'''


Every batch of [[wikipedia:Cannabis|cannabis]] sold legally in California must be tested for more than 100 contaminants. These contaminants include 66 pesticides, for 21 of which the state's tolerance is zero. For many other substances, tolerance levels are much lower than those allowed for food products in California. This article reviews the state's testing [[Regulatory compliance|regulations]] in context—including maximum allowable tolerance levels—and uses primary data collected from California's major cannabis testing [[Laboratory|laboratories]] and several cannabis testing equipment manufacturers, as well as a variety of expert opinions, to estimate the cost per pound of testing under the state's framework. We also estimate the cost of collecting [[Sample (material)|samples]], which depends on the distance between cannabis distributors and laboratories. We find that, if a batch fails mandatory tests, the value of cannabis that must be destroyed accounts for a large share of total testing costs, more than the cost of the tests that laboratories perform. Findings from this article will help readers understand the effects of California's testing regime on the price of legal cannabis in the state, and understand how testing may add value to products that have passed a series of tests that aim to validate their safety. ('''[[Journal:Costs of mandatory cannabis testing in California|Full article...]]''')<br />
n autoverification system for coagulation consists of a series of rules that allows normal data to be released without manual verification. With new advances in [[medical informatics]], the [[laboratory information system]] (LIS) has growing potential for the use of autoverification, allowing rapid and accurate verification of [[clinical laboratory]] tests. The purpose of the study is to develop and evaluate a LIS-based autoverification system for validation and efficiency.
 
Autoverification decision rules—including quality control, analytical error flag, critical value, limited range check, delta check, and logical check rules, as well as patient’s historical information—were integrated into the LIS. Autoverification limit ranges was constructed based on 5% and 95% percentiles. The four most commonly used coagulation assays—prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (FBG)—were followed by the autoverification protocols. ('''[[Journal:Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory|Full article...]]''')<br />
<br />
<br />
''Recently featured'':
''Recently featured'':
: ▪ [[Journal:CyberMaster: An expert system to guide the development of cybersecurity curricula|CyberMaster: An expert system to guide the development of cybersecurity curricula]]
: ▪ [[Journal:Costs of mandatory cannabis testing in California|Costs of mandatory cannabis testing in California]]
: ▪ [[Journal:An integrated data analytics platform|An integrated data analytics platform]]
: ▪ [[Journal:An integrated data analytics platform|An integrated data analytics platform]]
: ▪ [[Journal:Virtualization-based security techniques on mobile cloud computing: Research gaps and challenges|Virtualization-based security techniques on mobile cloud computing: Research gaps and challenges]]
: ▪ [[Journal:Building open access to research (OAR) data infrastructure at NIST|Building open access to research (OAR) data infrastructure at NIST]]

Revision as of 15:52, 11 November 2019

Fig1 Wang BMCMedInfoDecMak2019 19-1.png

"Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory"

n autoverification system for coagulation consists of a series of rules that allows normal data to be released without manual verification. With new advances in medical informatics, the laboratory information system (LIS) has growing potential for the use of autoverification, allowing rapid and accurate verification of clinical laboratory tests. The purpose of the study is to develop and evaluate a LIS-based autoverification system for validation and efficiency.

Autoverification decision rules—including quality control, analytical error flag, critical value, limited range check, delta check, and logical check rules, as well as patient’s historical information—were integrated into the LIS. Autoverification limit ranges was constructed based on 5% and 95% percentiles. The four most commonly used coagulation assays—prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (FBG)—were followed by the autoverification protocols. (Full article...)

Recently featured:

▪ CyberMaster: An expert system to guide the development of cybersecurity curricula
▪ Costs of mandatory cannabis testing in California
▪ An integrated data analytics platform
Retrieved from "https://www.limswiki.org/index.php?title=Template:Article_of_the_week&oldid=36842"